• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Janssen CNS

Quote




























looks like the tenure peole have already started leaving. This division is a screwed! They have all the relationships and the CV people just don’t get it. No way they can launch this product successfully!
 








anonymous said:
looks like the tenure peole have already started leaving. This division is a screwed! They have all the relationships and the CV people just don’t get it. No way they can launch this product successfully!
Click to expand...

Disagree - not many of the tenured people will go anywhere - because where will they go? What relevant marketplace skill sets do they have? Not many...other than what Jansen has brainwashed them on or maybe they can take a primary job (which is what this really is).

You all think you have key substantial relationships, but you really don’t, which is the common ego-centric misconception across Jansen/CNS.

The unsuccessful launch will mostly be because of the cluster@#$& plan (or lack of) from this brand team. They literally have no clue and have created chaos and hysteria with the multiple conflicting messages and “strategies” with the NS field organization and SCG/IBG. If inbred fighting over account ownership and desperation for recognition is what they are looking for, then they nailed it. If the goal is truly to launch and grow a product, then they are failing miserably already.
 




anonymous said:
Disagree - not many of the tenured people will go anywhere - because where will they go? What relevant marketplace skill sets do they have? Not many...other than what Jansen has brainwashed them on or maybe they can take a primary job (which is what this really is).

You all think you have key substantial relationships, but you really don’t, which is the common ego-centric misconception across Jansen/CNS.

The unsuccessful launch will mostly be because of the cluster@#$& plan (or lack of) from this brand team. They literally have no clue and have created chaos and hysteria with the multiple conflicting messages and “strategies” with the NS field organization and SCG/IBG. If inbred fighting over account ownership and desperation for recognition is what they are looking for, then they nailed it. If the goal is truly to launch and grow a product, then they are failing miserably already.
Click to expand...

Can I ask what product all this launch discussion is about?
 




anonymous said:
Disagree - not many of the tenured people will go anywhere - because where will they go? What relevant marketplace skill sets do they have? Not many...other than what Jansen has brainwashed them on or maybe they can take a primary job (which is what this really is).

You all think you have key substantial relationships, but you really don’t, which is the common ego-centric misconception across Jansen/CNS.

The unsuccessful launch will mostly be because of the cluster@#$& plan (or lack of) from this brand team. They literally have no clue and have created chaos and hysteria with the multiple conflicting messages and “strategies” with the NS field organization and SCG/IBG. If inbred fighting over account ownership and desperation for recognition is what they are looking for, then they nailed it. If the goal is truly to launch and grow a product, then they are failing miserably already.
Click to expand...


It is interesting that if you complain about J&J pay that the people who jump down your throat defending the company are always those who have been here for life and are never going anywhere else. Golden handcuffs.
 




























anonymous said:
Disagree - not many of the tenured people will go anywhere - because where will they go? What relevant marketplace skill sets do they have? Not many...other than what Jansen has brainwashed them on or maybe they can take a primary job (which is what this really is).

You all think you have key substantial relationships, but you really don’t, which is the common ego-centric misconception across Jansen/CNS.

The unsuccessful launch will mostly be because of the cluster@#$& plan (or lack of) from this brand team. They literally have no clue and have created chaos and hysteria with the multiple conflicting messages and “strategies” with the NS field organization and SCG/IBG. If inbred fighting over account ownership and desperation for recognition is what they are looking for, then they nailed it. If the goal is truly to launch and grow a product, then they are failing miserably already.
Click to expand...

The meetings look like an AARP convention. People stay because of the pension and if they don't rock the boat, they can retire with some security. That's if we even get the pension by the time we retire.

The hiring and retention of "tenured reps with relationships" is a joke. The KAM in my territory didn't have any access to accounts they claimed to have stellar relationships so they started calling on outpatient targets that were easy to see.

What a clusterfuck...lol
 




anonymous said:
Launching now with a sales group that isn’t capable of tying their own shoe laces. Isn’t big Pharma great?
Click to expand...
They want robots. Stick to a script and click in an exact order on the IPad. God forbid you have a real engaging conversation. This isn’t diabetes... it’s mental health where you have in-depth conversations and there are tons of variables. It’s amazing to see how fast new leadership can drive a culture in the toilet. Out of touch and unable to relate or understand the disease state and complexity of getting a health system set up. #whatashame
 




Top Bottom
Back
Quote